Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Senti Biosciences, Inc. - Common Stock
(NQ:
SNTI
)
0.2760
-0.0430 (-13.48%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Senti Biosciences, Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
Why Is Beyond Air (XAIR) Stock Down 22% Today?
June 25, 2024
Beyond Air stock is down on Tuesday as investors in XAIR react to the company mixed earnings report for the first quarter of the year.
Via
InvestorPlace
Why Is Faraday Future (FFIE) Stock Down 27% Today?
June 25, 2024
Faraday Future stock is down on Tuesday after the troubled EV company announced plans for a reverse split of FFIE shares.
Via
InvestorPlace
Why Is Senti Biosciences (SNTI) Stock Up 32% Today?
June 25, 2024
Senti Biosciences stock is up on Tuesday with heavy pre-market trading of SNTI shares despite a lack of news from the company.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
June 25, 2024
Pre-market stock movers are worth checking out on Tuesday as we get into all of the hottest news worth reading about this morning!
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's After-Market Session
June 07, 2024
Via
Benzinga
SNTI Stock Earnings: Senti Biosciences Reported Results for Q1 2024
May 09, 2024
Senti Biosciences just reported results for the first quarter of 2024.
Via
InvestorPlace
Senti Bio Announces First Patient Dosed in Phase 1 Clinical Trial of SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid Leukemia
May 13, 2024
From
Senti Biosciences, Inc.
Via
GlobeNewswire
Senti Bio Announces First Quarter 2024 Results and Reviews Recent Corporate Highlights
May 09, 2024
From
Senti Biosciences, Inc.
Via
GlobeNewswire
Senti Bio Announces Publication of SENTI-202 Preclinical Data Demonstrating Potential of Logic-Gated CAR-NK Cell Therapy for the Treatment of Acute Myeloid Leukemia (AML)
April 30, 2024
From
Senti Biosciences, Inc.
Via
GlobeNewswire
SNTI Stock Earnings: Senti Biosciences Misses EPS for Q4 2023
March 21, 2024
SNTI stock results show that Senti Biosciences missed analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Senti Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Reviews Recent Highlights
March 21, 2024
From
Senti Biosciences, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 23, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 22, 2024
Via
Benzinga
Senti Bio Announces Strategic Steps to Prioritize Investment in Lead Clinical Program
January 05, 2024
From
Senti Biosciences, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 25, 2023
Via
Benzinga
Why Is Blood Cancer Focused Senti Biosciences Stock Trading Higher Today?
December 22, 2023
Senti Biosciences Inc (NASDAQ: SNTI) received FDA clearance for its Investigational New Drug (IND) application for SENTI-202, an off-the-shelf chimeric antigen receptor natural killer (CAR-NK) cell...
Via
Benzinga
Exposures
Product Safety
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 22, 2023
Via
Benzinga
Senti Bio Announces FDA Clearance of IND Application for SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid Leukemia
December 22, 2023
From
Senti Biosciences, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
December 18, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
December 12, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
December 12, 2023
Checking out the biggest pre-market stock movers for Tuesday is the perfect way to get ready for another busy day of trading!
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
December 07, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
November 16, 2023
It's time to start the day with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Thursday!
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
November 13, 2023
Via
Benzinga
Senti Bio Announces Third Quarter 2023 Results and Pipeline Updates
November 13, 2023
From
Senti Biosciences, Inc.
Via
GlobeNewswire
Week In Review: Eccogen Out-Licenses GLP-1 Agonist To AstraZeneca In $2 Billion Deal
November 11, 2023
Eccogene, a Shanghai-Boston biotech, out-licensed global rights (ex-China) for its novel small molecule GLP-1 agonist to AstraZeneca in a $2 billion blockbuster deal. Eccogene will receive $185 million...
Via
Talk Markets
12 Health Care Stocks Moving In Wednesday's Intraday Session
November 08, 2023
Via
Benzinga
Crude Oil Falls Sharply; Datadog Shares Spike Higher
November 07, 2023
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 1% on Tuesday The Dow traded up 0.21% to 34,166.89 while the NASDAQ rose 1.09% to 13,666.65. The S&P 500...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
12 Health Care Stocks Moving In Tuesday's Intraday Session
November 07, 2023
Via
Benzinga
Why Sanmina Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
November 07, 2023
Gainers PaxMedica, Inc. (NASDAQ: PXMD) shares climbed 173.8% to $8.35. PaxMedica announced the publication of its autism spectrum disorder Phase 2 study results in the Annals of General Psychiatry.
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.